Brown Advisory
CDMO

Brown Advisory’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Brown Advisory’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,569
Closed -$367K – 1269
2021
Q4 		$367K Buy
+12,569
New +$360K ﹤0.01% 974

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Brown Advisory's CDMO Position: Q1 2022 in Review

Brown Advisory sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2022, closing a stake of 12,569 shares — an estimated $367K sold.

Brown Advisory first reported a position in CDMO in Q4 2021 and held it in 1 quarter. The position peaked at $367K in Q4 2021. 193 funds tracked by Wall St. Rank hold CDMO as of Q1 2022.

  • Brown Advisory reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Brown Advisory sold 12,569 Avid Bioservices, Inc. Common Stock shares in Q1 2022, an estimated $367K.
  • Brown Advisory first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Brown Advisory's Avid Bioservices, Inc. Common Stock position peaked at $367K in Q4 2021.
  • 193 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2022.

Based on Brown Advisory's 13F filing for Q1 2022, filed 9 May 2022.